Fred Racine

Statistics

Publications

Citations

1.1K

H-Index

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Scynexis (United States)

MSD (Spain)

United States Military Academy

Fred Racine is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, life sciences, and antibiotic resistance.

ORCID

Publications per year

2006–2020

Publications

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties

Jun Wang, Srinivas Kodali, Sang Ho Lee et al. · Proceedings of the National Academy of Sciences · 2007 · 380 citations · Full text

Life Sciences, Microbiology, Pharmacology +14

Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography

Peter Orth, Li Xiao, Lorraine D. Hernandez et al. · Journal of Biological Chemistry · 2014 · 138 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

Katherine Young, Ronald E. Painter, Susan L. Raghoobar et al. · BMC Microbiology · 2019 · 125 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model

Jin Wu, Fred Racine, Michael K. Wismer et al. · Antimicrobial Agents and Chemotherapy · 2018 · 64 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Caspofungin Susceptibility in Aspergillus and Non- Aspergillus Molds: Inhibition of Glucan Synthase and Reduction of β- <scp>d</scp> -1,3 Glucan Levels in Culture

Jennifer Nielsen Kahn, Ming‐Jo Hsu, Fred Racine et al. · Antimicrobial Agents and Chemotherapy · 2006 · 62 citations · Full text

Life Sciences, Microbiology, Host-pathogen Interactions +16

1–5 of 13